REGINfo: VIFOR PHARMA - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DELEK GROUP
- DISCOUNT
- ELBIT SYSTEMS
- Energean Oil Gas
- FIBI BANK
- GAZIT GLOBE
- HAREL
- ICL
- IFF
- ISRAEL CORP
- LEUMI
- LivePerson
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- Phoenix Group Holdings
- POALIM
- SHUFERSAL
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

COMPANY SEARCH RESULT

$VIFOR PHARMA: Click to view the issuer\'s details$

Last update : 21/08/2018 >View issuer details

2020.05.18 | 05:00 | Permanent Information Releases / General Company News

puce VFMCRP and ChemoCentryx announce topline data from phase-II LUMINA-1 trial of CCX140 in Focal Segmental Glomerulosclerosis (FSGS) - HTML (w)

2020.05.14 | 15:35 | Annual General Meeting / Reports

puce 92nd Vifor Pharma Group Annual General Meeting - HTML (w)

2020.05.14 | 15:35 | Annual General Meeting / Reports

puce 92e assemblée générale annuelle du groupe Vifor Pharma - HTML (w)

2020.05.05 | 11:01 | Permanent Information Releases / General Company News

puce Vifor Pharma Announces Akebia’s Positive Top-Line Results From Global Phase-III Program of vadadustat for Treatment of Anaemia Due to Chronic Kidney Disease in Adult Dialysis-Dependent Patients - HTML (w)

2020.04.21 | 05:30 | Permanent Information Releases / General Company News

puce VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus - HTML (w)

2020.03.31 | 05:00 | Annual General Meeting / AGM

puce Update on 92nd Vifor Pharma Ltd. Annual General Meeting - HTML (w)

2020.03.31 | 05:00 | Annual General Meeting / AGM

puce Communiqué concernant la 92e assemblée générale annuelle de Vifor Pharma SA - HTML (w)

2020.03.12 | 06:00 | Permanent Information Releases / General Company News

puce Vifor Pharma Group Reports Strong Growth in 2019, Exceeding Raised Guidance - HTML (w)

2020.03.12 | 06:00 | Permanent Information Releases / General Company News

puce En 2019, le groupe Vifor Pharma a enregistré une forte croissance, supérieure aux prévisions - HTML (w)

2020.03.05 | Periodic information / Annual Financial Report

puce VIFOR PHARMA : ANNUAL REPORT 2019 - PDF (8Mb)

2020.02.20 | 06:00 | Permanent Information Releases / General Company News

puce Vifor Pharma and Fresenius Kabi create joint venture in China for i.v. iron portfolio - HTML (w)

2019.11.26 | 07:00 | Permanent Information Releases / General Company News

puce Vifor Pharma raises awareness on Iron Deficiency Day 2019 for people around the world to take iron seriously - HTML (w)

2019.11.26 | 06:00 | Permanent Information Releases / General Company News

puce VFMCRP and ChemoCentryx Announce Positive Topline Data From Pivotal Phase-III ADVOCATE Trial Demonstrating Avacopan’s Superiority Over Standard of Care in ANCA Associated Vasculitis - HTML (w)

2019.08.08 | Periodic information / Half-Year Financial Report

puce VIFOR PHARMA : HALF-YEAR REPORT 2019 - PDF (3Mb)

2019.05.21 | 05:00 | Permanent Information Releases / General Company News

puce First patient treated in DIAMOND study to evaluate if Veltassa® (patiromer) improves outcomes by enabling long-term use of essential RAASi therapy - HTML (w)

Pages : 1 - 2 / Doc nb : 30